Updated:
BioClinica - CCBR-SYNARC Inc.
BioClinica - CCBR-SYNARC Inc. is a Princeton-based combined clinical CRO and imaging core lab formed through merger, serving pharmaceutical trials.
BioClinica - CCBR-SYNARC Inc.
BioClinica - CCBR-SYNARC Inc. was formed through the merger of BioClinica, a global clinical trial management firm, and CCBR-SYNARC, a specialized imaging core lab. The combined entity offers integrated services for biopharmaceutical companies, including clinical trial design, data management, and medical imaging analysis. The firm provides clinical research organization (CRO) services and imaging solutions across multiple therapeutic areas. Its client base includes pharmaceutical and biotechnology companies sponsoring Phase I through Phase IV trials. The firm's imaging division supports regulatory submissions with quantitative imaging biomarkers. No team size, recent operational events, or additional offices were publicly verifiable at the time of research. The entity appears to operate solely from its Princeton headquarters. The structural differentiator is its dual specialization in both traditional CRO services and advanced imaging core lab work, a combination less common among larger full-service CROs.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Princeton
Corporate office
Princeton, NJ, United States
Sector focus
Frequently asked questions
What services does BioClinica - CCBR-SYNARC Inc. offer?
The firm provides clinical trial management and medical imaging core lab services to pharmaceutical and biotechnology sponsors. This includes protocol design, data management, biostatistics, and quantitative imaging analysis for regulatory submissions.
How was BioClinica - CCBR-SYNARC Inc. formed?
The entity is a combination of two legacy organizations: BioClinica, a clinical trial services provider, and CCBR-SYNARC, an imaging core lab. The merger created a single firm offering both end-to-end clinical trial management and specialized imaging endpoints.
What therapeutic areas does the firm cover?
Based on its imaging and clinical trial capabilities, the firm supports trials across a range of therapeutic areas, including oncology, neurology, cardiovascular, and musculoskeletal diseases. Imaging biomarkers are particularly relevant in conditions requiring quantitative measurement of disease progression.
Is BioClinica - CCBR-SYNARC Inc. a family office or an asset manager?
Public records indicate the firm operates as a clinical research organization providing services rather than as a traditional asset manager or family office. Its revenue model is based on service contracts, not investment capital.
Does the firm have publicly available financial information?
No AUM, revenue, or financial details were publicly disclosed at the time of research. The firm operates as a private entity without public SEC filings typically associated with registered investment advisors.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: